posted on 2023-05-20, 04:36authored byGogos, A, Ney, LJ, Seymour, N, Van Rheenen, TE, Felmingham, KL
In this review, we describe the sex differences in prevalence, onset, symptom profiles and disease outcome that are evident in schizophrenia, bipolar disorder and post-traumatic stress disorder. Women with schizophrenia tend to exhibit less disease impairment than men; by contrast, women with post-traumatic stress disorder are more affected than men. The most likely candidates to explain these sex differences are gonadal hormones. This review details the clinical evidence that estradiol and progesterone are dysregulated in these psychiatric disorders. Notably, existing data on estradiol, and to a lesser extent, progesterone, suggest that low levels of these hormones may increase the risk of disease development and worsen symptom severity. We argue that future studies require a more inclusive, considered analysis of gonadal steroid hormones and the intricacies of the interactions between them, with methodological rigour applied, to enhance our understanding of the roles of steroid hormones in psychiatric disorders.
History
Publication title
British Journal of Pharmacology
Volume
176
Issue
21
Pagination
4119-4135
ISSN
1476-5381
Department/School
School of Psychological Sciences
Publisher
John Wiley & Sons Ltd.
Place of publication
United Kingdom
Rights statement
Copyright 2019 The British Pharmacological Society. This is the pre-peer reviewed version of the article, which has been published in final form at http://dx.doi.org/10.1111/bph.14584. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.